BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1452198)

  • 1. Inhibition of murine erythroleukemia cell differentiation by normal and partially deleted c-myc genes.
    Bar-Ner M; Messing LT; Segal S
    Immunobiology; 1992 Aug; 185(2-4):150-8. PubMed ID: 1452198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
    Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S
    Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional domains of c-Myc involved in the commitment and differentiation of murine erythroleukemia cells.
    Ohmori Y; Tanabe J; Takada S; Lee WM; Obinata M
    Oncogene; 1993 Feb; 8(2):379-86. PubMed ID: 8426744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of murine Max (Myn) parallels the regulation of c-Myc in differentiating murine erythroleukemia cells.
    Dunn BK; Cogliati T; Cultraro CM; Bar-Ner M; Segal S
    Cell Growth Differ; 1994 Aug; 5(8):847-54. PubMed ID: 7986749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
    Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
    J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells.
    Cogliati T; Dunn BK; Bar-Ner M; Cultraro CM; Segal S
    Oncogene; 1993 May; 8(5):1263-8. PubMed ID: 8479748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
    Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters.
    Kohlhuber F; Strobl LJ; Eick D
    Oncogene; 1993 Apr; 8(4):1099-102. PubMed ID: 8455938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of c-Myc on erythroid differentiation.
    Ohmori Y; Tanabe J; Terashima M; Shoji W; Takada S; Obinata M
    Tohoku J Exp Med; 1992 Oct; 168(2):203-10. PubMed ID: 1306305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Prochownik EV; Kukowska J
    Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
    Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
    Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation-dependent repression of c-myc, B22, COX II and COX IV genes in murine erythroleukemia (MEL) cells.
    Vizirianakis IS; Pappas IS; Tsiftsoglou AS
    Biochem Pharmacol; 2002 Mar; 63(5):1009-17. PubMed ID: 11911854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between expression of c-myc and P53 genes and terminal differentiation during induced differentiation in Friend erythroleukemia cells].
    Liu HT; Zhang HQ; Xue SB; Du CY; You JS; Song PG; Wang XL; Chen RX
    Shi Yan Sheng Wu Xue Bao; 1988 Sep; 21(3):311-9. PubMed ID: 3066081
    [No Abstract]   [Full Text] [Related]  

  • 16. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differentiation and malignant suppression induced by mouse erythroid differentiation and denucleation factor on mouse erythroleukemia cells].
    Zhao Q; Ge YH; Zhou JP; Ma J; Chen KQ; Xue SP; Han DS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):32-5. PubMed ID: 12905814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of c-Myc inhibits the appearance of a specific DNase I hypersensitive site in the beta-globin chromatin in murine erythroleukemia cells.
    Takada S; Obinata M
    Jpn J Cancer Res; 1991 Apr; 82(4):376-9. PubMed ID: 1904416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation.
    Suhasini M; Reddy CD; Reddy EP; DiDonato JA; Pilz RB
    Oncogene; 1997 Oct; 15(15):1859-70. PubMed ID: 9362453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.